Acelyrin Accounts Payable

Acelyrin (SLRN) currently reports a accounts payable of $9.9M as of March 2025. That compares with $10M in the prior-year period — down 0.6% year over year. Use the charts on this page to explore Acelyrin's accounts payable history and peer comparisons.

Acelyrin's accounts payable decreased from $10M to $9.9M — a 0.6% year-over-year decrease (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Acelyrin reported $9.9M in accounts payable as of March 2025. That compares with $10M in the prior-year period — down 0.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $9.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Acelyrin, and consider following SLRN for alerts when major investors trade the stock.